INSMED INC Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INSMED INC stock issued during period, value, conversion of convertible securities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- INSMED INC stock issued during period, value, conversion of convertible securities for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- INSMED INC stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was $566.14M.
- INSMED INC stock issued during period, value, conversion of convertible securities for the quarter ending 2025-03-31 was $5.00K.
- INSMED INC stock issued during period, value, conversion of convertible securities for fiscal 2025 was $566.14M, a 152.38% increase from fiscal 2024.
- INSMED INC stock issued during period, value, conversion of convertible securities for fiscal 2024 was $224.32M.
- INSMED INC stock issued during period, value, conversion of convertible securities for fiscal 2012 was $0.00.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $566.14M 10-K · filed 2026-02-19 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $566.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $566.14M 10-Q · filed 2026-08-06 | $790.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $5.00K 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $224.32M 10-K · filed 2026-02-19 |
| 2024-09-30 | $224.26M 10-Q · filed 2025-10-30 | |
| 2012-12-31 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |